Grants and Contributions:
Title:
Vaccine and therapeutic target discovery effort: glycosylated RNAs on viruses
Agreement Number:
1015283
Agreement Value:
$24,998.00
Agreement Date:
Mar 26, 2024 - Sep 30, 2025
Description:
Advances exploratory research under the New Beginnings Initiative
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators.
Location:
Quebec, Quebec, CA G1K 9A9
Reference Number:
172-2023-2024-Q4-1015283
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
108161266
Recipient Type:
Academia
Recipient's Legal Name:
Institut national de la recherche scientifique
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Collaborative Science, Technology and Innovation Program – Ideation Fund
Program Purpose:
The Ideation Fund is intended to encourage, test and validate transformative research ideas generated by teams of NRC scientific personnel and external collaborators with complementary capabilities, acting as a demonstration phase for a continually-evolving suite of research and development (R&D) deliverables at the NRC. The fund supports exploratory research through two mechanisms: the New Beginnings Initiative and the Small Teams Initiative.
NAICS Code:
541710 - R&D in the physical, engineering and life sciences